SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology. 1985; 88: 18181825.
  • 2
    Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002; 8: 244250.
  • 3
    Achkar JP, Shen B. Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence. Curr Gastroenterol Rep. 2001; 3: 484490.
  • 4
    Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990; 99: 956963.
  • 5
    Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut. 1984; 25: 665672.
  • 6
    D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal excluded ileum. Gastroenterology. 1998; 114: 262267.
  • 7
    Lock MR, Farmer RG, Fazio VW, et al. Recurrence and reoperation for Crohn's disease: the role of disease location in prognosis. N Engl J Med. 1981; 304: 15861588.
  • 8
    Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology. 1996; 110: 424431.
  • 9
    Cottone M, Rosselli M, Orlando A, et al. Smoking habit and recurrence in Crohn's disease. Gastroenterology. 1994; 106: 643648.
  • 10
    Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology. 1998; 115: 259267.
  • 11
    Whelan G, Farmer RG, Fazio VW, et al. Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology. 1985; 88: 18261833.
  • 12
    Camma C, Giunta M, Rosselli M, et al. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology. 1997; 113: 14651473.
  • 13
    Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology. 2000; 118: 264273.
  • 14
    Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology. 1995; 108: 16171621.
  • 15
    Rutgeerts P, Van Assache G, Vermeire S, et al. Ordinazole for prophylaxis of post-operative Crohn's disease recurrence: a randomized, double blind, placebo-controlled trial. Gastroenterology. 2005; 128: 856861.
  • 16
    Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology. 2004; 127: 730740.
  • 17
    Hanauer SB, Korelitz BI, Rutgeerts P, et al. Post-operative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004; 127: 723729.
  • 18
    D'Haens G, Noman M, Van Assche G, et al. Severe post-operative recurrence of Crohn's disease is significantly reduced with combination therapy metronidazole and azathioprine: a double-blind controlled randomized trial. Gastroenterology. 2007; 132: 289.
  • 19
    Antonius JL, Gump FE, Lattes R, et al. A study of certain microscopic features in regional enteritis, and their possible prognostic significance. Gastroenterology. 1960; 38: 889905.
  • 20
    Glass RE, Baker WN. Role of granuloma in recurrent Crohn's disease. Gut. 1976; 17: 7577.
  • 21
    Anseline PF, Wlodarczyk J, Murugasu R. Presence of granulomas is associated with recurrence after surgery for Crohn's disease: experience of a surgical unit. Br J Surg. 1997; 84: 7882.
  • 22
    Davis DR, Dockerty MB, Mayo CW. The myenteric plexus in regional enteritis: a study of the number of ganglion cells in the ileum in 24 cases. Surg Gynaecol Obstet. 1955; 101: 208216.
  • 23
    Siermers PT, Dobbins WOIII. The Meissner plexus in Crohn's disease of the colon. Surg Gynae Obstet. 1974; 138: 3942.
  • 24
    Geboes K, Collins S. Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterol Motil. 1998; 10: 189202.
  • 25
    Ferrante M, de Hertogh G, Hlavaty, et al. The value of myenteric plexitis to predict early post-operative Crohn's disease recurrence. Gastroenterology. 2006; 130: 15951606.
  • 26
    Ng SC, Kamm MA. Review: management of post-operative Crohn's disease. Am J Gastroenterol. 2008; 103: 10291035.
    Direct Link:
  • 27
    De Dombal FT, Burton I, Goligher C. The early and late results of surgical treatment for Crohn's disease. Br J Surg. 1971; 11: 805816.
  • 28
    Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut. 1988; 29: 588592.
  • 29
    Simillis C, Yamamoto T, Reese GE, et al. A meta-analysis comparing incidence of recurrewnce and indications for reoperation after surgery for perforating versus nonperforating Crohn's disease. Am J Gastroenterol. 2008; 103: 196205.
    Direct Link:
  • 30
    Hirata I, Berrebi G, Austin LL, et al. Immunohistochemical characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon in inflammatory bowel disease. Dig Dis Sci. 1986; 31: 593603.
  • 31
    Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology. 1996; 111: 16831699.
  • 32
    Rulh A, Collins M. Enteroglial cells are an integral part of the neuroimmune axis in the gut. Gastroenterology. 1995; 108: A650.
  • 33
    Ruhl A, Franzke S, Collins SM, et al. Interleukin-6 expression and regulation in rat enteric glial cells. Am J Physiol Gastrointest Liver Physiol. 2001; 280: G11631171.
  • 34
    Nemi R, Fazio R, Corbo M, et al. Peripheral neuropathy associated with Crohn's disease. Neurology. 1987; 37: 14141417.
  • 35
    Ewe K, Bottger T, Buhr HJ, et al. Low-dose budesonide treatment for prevention of post-operative recurrence of Crohn's disease: a multi-centre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol. 1999; 11: 277282.
  • 36
    Hellers G, Cortot A, Jewells D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology. 1999; 116: 294300.
  • 37
    Glass RE, Baker WNW. Role of the granuloma in recurrent Crohn's disease. Gut. 1976; 17: 7577.
  • 38
    Chambers TJ, Morson BC. The granuloma in Crohn's disease. Gut. 1979; 20: 269274.
  • 39
    Wolfson DM, Sachar DB, Cohen A, et al. Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology. 1982; 83: 405409.
  • 40
    Heimann TM, Miller F, Martinelli G, et al. Correlation of presence of granulomas with clinical and immunologic variables in Crohn's disease. Arch Sur. 1988; 123: 4648.
  • 41
    Molnar T, Tiszlavicz L, Gyulai C, et al. Clinical significance of granuloma in Crohn's disease. World J Gastroenterol. 2005; 28: 31183121.